Regeneron Pops After Covid Treatment Beats First-Quarter Views

Regeneron Pops After Covid Treatment Beats First-Quarter Views

Regeneron stock inched higher Thursday after the biotech company's Covid-19 antibody treatment delivered a narrow first-quarter beat. Overall, sales were in line and earnings beat.